Get the Stockscreener App
1.86
4.49%
0.08
After Hours:
1.90
0.04
+2.15%
Alector Inc stock is traded at $1.86, with a volume of 3.86M.
It is up +4.49% in the last 24 hours and down -48.83% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.78
Open:
$1.76
24h Volume:
3.86M
Relative Volume:
3.54
Market Cap:
$182.15M
Revenue:
$97.06M
Net Income/Loss:
$-130.39M
P/E Ratio:
-1.0814
EPS:
-1.72
Net Cash Flow:
$-186.54M
1W Performance:
-5.58%
1M Performance:
-48.83%
6M Performance:
-55.61%
1Y Performance:
-76.40%
1-Day Range:
$1.725
$1.885
1-Week Range:
$1.725
$2.02
52-Week Range:
$1.725
$8.90
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.86 | 182.15M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Alector stock hits 52-week low at $1.73 amid market challenges - Investing.com Australia
Alector (NASDAQ:ALEC) Rating Lowered to “Neutral” at Mizuho - Defense World
BNP Paribas Financial Markets Cuts Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Rating Lowered by Mizuho - MarketBeat
Alector stock under pressure as key AL002 program removed—Mizuho - Investing.com
Alector stock under pressure as key AL002 program removed—Mizuho By Investing.com - Investing.com UK
Alector Inc. stock downgraded to Hold by Stifel, amid mixed biotechnology outlook - Investing.com Australia
Alector (NASDAQ:ALEC) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Stifel Downgrades Alector (ALEC) - MSN
Verition Fund Management LLC Sells 473,794 Shares of Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Alector stock hits 52-week low at $1.99 amid market challenges - Investing.com Australia
Short Interest in Alector, Inc. (NASDAQ:ALEC) Grows By 34.1% - MarketBeat
Alector, Inc. (NASDAQ:ALEC) Sees Large Growth in Short Interest - Defense World
Alector (ALEC) Stock Dips Amid Biotech Sector Volatility - GuruFocus.com
Point72 Asset Management L.P. Sells 529,847 Shares of Alector, Inc. (NASDAQ:ALEC) - MarketBeat
RA Capital Management, L.P. Acquires Significant Stake in Alecto - GuruFocus.com
Bank of America Downgrades Alector (NASDAQ:ALEC) to Underperform - Defense World
Alector downgraded to Underperform at BofA after Alzheimer's trial miss - MSN
Alector stock hits 52-week low at $2.36 amid market challenges - Investing.com Canada
Neurology-Focused Alector Downgraded On Failed Alzheimer's Study, BofA Securities Highlights Lack Of Catalysts - Benzinga
Alector (NASDAQ:ALEC) Downgraded to Underperform Rating by Bank of America - MarketBeat
Alector CFO Marc Grasso sells $41,542 in stock By Investing.com - Investing.com Canada
Alector's chief medical officer sells shares worth $37,518 By Investing.com - Investing.com Canada
Alector's chief medical officer sells shares worth $37,518 - Investing.com
Alector president and head of R&D sells $66,764 in stock - Investing.com
Alector president and head of R&D sells $66,764 in stock By Investing.com - Investing.com Canada
Alector CEO Rosenthal sells over $131,000 in stock - Investing.com
Alector CFO Marc Grasso sells $41,542 in stock - Investing.com
Alector CEO Rosenthal sells over $131,000 in stock By Investing.com - Investing.com UK
Deutsche Bank Initiates Coverage of Alector (ALEC) with Buy Recommendation - MSN
Vigil Neuroscience: Down On A Competitor's Failure (NASDAQ:VIGL) - Seeking Alpha
Alector (ALEC) Stock Drops 5.02% Amidst Market Volatility - GuruFocus.com
HC Wainwright Issues Pessimistic Forecast for Alector (NASDAQ:ALEC) Stock Price - Defense World
Braidwell LP Has $10.06 Million Stock Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
HC Wainwright Cuts Alector (NASDAQ:ALEC) Price Target to $7.00 - MarketBeat
Q1 Earnings Estimate for Alector Issued By HC Wainwright - MarketBeat
Need To Know: Analysts Just Made A Substantial Cut To Their Alector, Inc. (NASDAQ:ALEC) Estimates - Simply Wall St
Victory Capital Management Inc. Increases Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Rating Lowered by Morgan Stanley - Defense World
Alector shares price target cut, retains buy amid clinical trial setback - Investing.com Australia
Alector: Bleak Prospects After Alzheimer's Failure (NASDAQ:ALEC) - Seeking Alpha
ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study - Yahoo Finance
Alector price target lowered to $7 from $35 at H.C. Wainwright - Yahoo Finance
Alector AL002 INVOKE-2 Phase II Alzheimer’s trial misses goal - The Pharma Letter
Alector (NASDAQ:ALEC) Given New $5.00 Price Target at BTIG Research - Defense World
Alector stock hits 52-week low at $2.61 amid market challenges - Investing.com Canada
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Dec 02 '24 |
Sale |
2.52 |
52,172 |
131,442 |
2,507,074 |
| Kenkare-Mitra Sara | President and Head of R&D |
Dec 02 '24 |
Sale |
2.52 |
26,500 |
66,764 |
565,215 |
| Romano Gary | Chief Medical Officer |
Dec 02 '24 |
Sale |
2.52 |
14,892 |
37,519 |
349,283 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):